Gene · 5921
Papers3,549
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 3,549
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Network Pharmacology-Based Identification of Key Pharmacological Mechanism of Shen-qi-di-huang Decoction Acting on Uremia. | Altern Ther Health Med | 2024 | 37773677 | PubTator, text mining | PubMed |
| Lymphatic Malformations in Parkes Weber's Syndrome: Retrospective Review of 16 Cases in a Vascular Anomalies Center. | Eur J Pediatr Surg | 2024 | 37595632 | PubTator, text mining | PubMed |
| The Role of Small Extracellular Vesicles Derived from Mesenchymal Stromal Cells on Myocardial Protection: a Review of Current Advances and Future Perspectives. | Cardiovasc Drugs Ther | 2024 | 37227567 | PubTator, text mining | PubMed |
| Combined Hepatocellular-Cholangiocarcinoma With Ductal Plate Malformation Pattern: A Case Report With Molecular Analysis. | Int J Surg Pathol | 2024 | 37128663 | PubTator, text mining | PubMed |
| Strategic concept paper for bioeconomy in Poland: executive summary. | Open Res Eur | 2023 | 38481772 | PubTator, text mining | PubMed |
| The Anticancer Effects of Marine Carotenoid Fucoxanthin through Phosphatidylinositol 3-Kinase (PI3K)-AKT Signaling on Triple-Negative Breast Cancer Cells. | Molecules | 2023 | 38202644 | PubTator, text mining | PubMed |
| Pathogenic Variant Frequencies in Hereditary Haemorrhagic Telangiectasia Support Clinical Evidence of Protection from Myocardial Infarction. | J Clin Med | 2023 | 38202257 | PubTator, text mining | PubMed |
| Dysregulation of Lymphatic Endothelial VEGFR3 Signaling in Disease. | Cells | 2023 | 38201272 | PubTator, text mining | PubMed |
| Clinically Relevant Genetic Considerations for Patients With Tetralogy of Fallot. | CJC Pediatr Congenit Heart Dis | 2023 | 38161665 | PubTator, text mining | PubMed |
| The LINC01260 Functions as a Tumor Suppressor via the miR-562/CYLD/NF-κB Pathway in Non-Small Cell Lung Cancer [Retraction]. | Onco Targets Ther | 2023 | 38155749 | PubTator, text mining | PubMed |
| The role of circRNAs in regulation of drug resistance in ovarian cancer. | Front Genet | 2023 | 38152652 | PubTator, text mining | PubMed |
| CD6 and Its Interacting Partners: Newcomers to the Block of Cancer Immunotherapies. | Int J Mol Sci | 2023 | 38139340 | PubTator, text mining | PubMed |
| CD200/CD200R: Bidirectional Role in Cancer Progression and Immunotherapy. | Biomedicines | 2023 | 38137547 | PubTator, text mining | PubMed |
| Work-Up and Treatment Strategies for Individuals with PIK3CA-Related Disorders: A Consensus of Experts from the Scientific Committee of the Italian Macrodactyly and PROS Association. | Genes (Basel) | 2023 | 38136956 | PubTator, text mining | PubMed |
| Targeted therapies in bladder cancer: signaling pathways, applications, and challenges. | MedComm (2020) | 2023 | 38107059 | PubTator, text mining | PubMed |
| Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies. | Signal Transduct Target Ther | 2023 | 38105263 | PubTator, text mining | PubMed |
| Mimicking hypomethylation of FUS requires liquid-liquid phase separation to induce synaptic dysfunctions. | Acta Neuropathol Commun | 2023 | 38105257 | PubTator, text mining | PubMed |
| Long non-coding RNA and Evolving drug resistance in lung cancer. | Heliyon | 2023 | 38089985 | PubTator, text mining | PubMed |
| Epigenetic Dysregulation in MYCN-Amplified Neuroblastoma. | Int J Mol Sci | 2023 | 38069407 | PubTator, text mining | PubMed |
| The genomic and immune landscapes of gastric cancer and their correlations with HER2 amplification and PD-L1 expression. | Cancer Med | 2023 | 38050871 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5921/papers?page=9